Erez Raphael - Jan 19, 2021 Form 4/A - Amendment Insider Report for DarioHealth Corp. (DRIO)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Erez Raphael
Stock symbol
DRIO
Transactions as of
Jan 19, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/20/2021, 04:10 PM
Date Of Original Report
Jan 22, 2021
Next filing
Jul 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRIO Common Stock Award $0 +2.27K +0.43% $0.00 531K Jan 19, 2021 Direct F1
transaction DRIO Restricted Stock Grant Award $0 +413K +77.84% $0.00 944K Jan 19, 2021 Direct F2
holding DRIO Common Stock 37.9K Jan 19, 2021 By Dicilyon Consulting and Investment Ltd. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2021.
F2 The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter.
F3 The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.